Epilepsy, a chronic neurological disorder, demands continuous advancement in its management approaches.
Recent years have seen the introduction of new AEDs like cenobamate and cannabidiol, offering improved seizure control.
Neurostimulation therapies, such as Vagus Nerve Stimulation (VNS) and Responsive Neurostimulation (RNS), have shown promising results.
Genomic medicine, providing personalized treatment plans based on patients' genetic profiles, has revolutionized epilepsy management.
These advancements have significantly enhanced the quality of life for epilepsy patients, underscoring the importance of continuous research.
1.
In heavily pretreated DLBCL, Triplet Scores a Survival Victory.
2.
Radiation therapy for patients with breast cancer
3.
Video: How to treat kidney disease?
4.
Chemo-Free Triplet Yields 68% Response Rate in Richter Transformation
5.
GLP-1 RAs May Lower Hysterectomy Risk in Endometrial Cancer
1.
Unlocking the Potential of SCD: A Comprehensive Guide to Diagnosis and Treatment
2.
Quality of Life Following Organ Function Preserving Oncologic Innovation
3.
Interpreting Iron Studies: What Your Blood Results Really Mean
4.
Rehabilitation of Hand Dexterity Following Hematologic Treatment-Associated Deconditioning
5.
Surprising Symptoms of Prostate Cancer: What You Need to Know
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part III
2.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- Summarization of the New Perspective
3.
Early Cancer Detection Saves Lives
4.
L858R Mutation- An Overview of Retrospective Cohort Study in Advanced NSCLC Patients
5.
Daratumumab, Lenalidomide, and Dexamethasone (DRd) Versus Lenalidomide and Dexamethasone (Rd) in MRD Negativity
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation